Therapeutic effects of probiotic bacteria in parvoviral enteritis in dogs

Basit Öğe Kaydı
dc.contributor.authorArslan, H. H.
dc.contributor.authorAksu, D. Saripinar
dc.contributor.authorTerzi, G.
dc.contributor.authorNisbet, C.
dc.date.accessioned2024-09-18T20:06:26Z
dc.date.available2024-09-18T20:06:26Z
dc.date.issued2012
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractIn this study, the evaluation of therapeutic effects of probiotic bacteria, in comparison with single supportive and symptomatic therapy. in CPV (canine parvovirus) infection was aimed. A total of 20 naturally infected dogs, 1-6 months old, exhibiting enteritis and for which the diagnosis were confirmed by an ELISA commercially available test, were randomly divided into two equal groups. Only supportive and symptomatic therapy was applied in group I, whereas a commercial probiotic product which contained different probiotic bacteria (VSL#3) was used as adjuvant oral therapy in the group II. Clinical scores established from complete clinical examinations performed at the beginning and on every subsequent day during the therapy and haematological parameters determined before and 5 days after treatments were compared between the 2 groups. A moderate anaemia (low haemoglobinemia) coupled to reduction in the mean corpuscular volume and haemoglobin concentration was evidenced in 55% of parvovirus infected clogs and a relatively leukopenia when compared with after the treatment was observed in all diseased animals. Seven (70%) and nine (90%) dogs in the groups I and II respectively, survived during the trial. Moreover, the clinical scores have declined significantly more rapidly in the group II than in the group I. While the erythrocyte parameters have not significantly differed between the 2 groups, leukocyte and lymphocyte numerations were significantly improved during the treatment course only in clogs additionally treated with probiotics. The present study indicates that probiotics may be beneficial in CPV therapy. especially for shortening the recovery time, under optimal care conditions.en_US
dc.description.sponsorshipCommission of Scientific Research Projects of Ondokuz Mayis University [VET- 014]en_US
dc.description.sponsorshipThis study was supported by the Commission of Scientific Research Projects of Ondokuz Mayis University (Project No: VET- 014).en_US
dc.identifier.endpage59en_US
dc.identifier.issn0035-1555
dc.identifier.issn2258-0646
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84857813533en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage55en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/8518
dc.identifier.volume163en_US
dc.identifier.wosWOS:000311653300001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherEcole Nationale Veterinaire Toulouseen_US
dc.relation.ispartofRevue De Medecine Veterinaireen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanine parvoviral enteritisen_US
dc.subjectprobiotic bacteriaen_US
dc.subjectadjuvant treatmenten_US
dc.subjectmortality rateen_US
dc.subjectclinical recoveryen_US
dc.subjectleukocyteen_US
dc.subjectlymphocyteen_US
dc.titleTherapeutic effects of probiotic bacteria in parvoviral enteritis in dogsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full text
Boyut:
70.14 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu